CK Life Sciences’ Sequencio Therapeutics to Present New Data from Lead Cancer Vaccine Programmes at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting
HONG KONG SAR - Media OutReach Newswire - 4 November 2026 - Sequencio Therapeutics Company Limited ("Sequencio"), a subsidiary of CK Life Sciences Int'l., (Holdings) Inc.
